Cytochrome P450 2A6/7/13 anticorps
Aperçu rapide pour Cytochrome P450 2A6/7/13 anticorps (ABIN6261195)
Antigène
Reactivité
Hôte
Clonalité
Application
-
-
Specificité
- Cytochrome P450 2A6/7/13 Antibody detects endogenous levels of total Cytochrome P450 2A6/7/13
-
Réactivité croisée
- Humain
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human Cytochrome P450 2A6/7/13
-
Isotype
- IgG
-
-
-
Indications d'application
- WB 1:1000-3000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C.Stable for 12 months from date of receipt
-
Date de péremption
- 12 months
-
-
- Cytochrome P450 2A6/7/13
-
Sujet
-
Description: Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.
Gene: CYP2A6
-
Poids moléculaire
- 56 kDa
-
ID gène
- 1548
-
UniProt
- P11509, P20853, Q16696
Antigène
-